There is increasing attention focused upon cannabidiol (CBD), a non‐psychoactive derivative from cannabis that is advocated for various therapeutic uses. CBD undergoes metabolism via the CYP3A4 and CYP2C19 isoenzymes, and it appears that the compound may also be a...
Research presented at the 2019 Annual Meeting of the American Neurology suggests that medicinal cannabis may have utility for older people. The retrospective chart review involved people 75 years of age or older, who accessed products under the New York State Medical...
Conventional wisdom has held that it is necessary to start intravenous thrombolytic treatment for acute ischemic stroke within 4.5 hours of the onset of symptoms. Results of a multicentre, randomized, placebo-controlled trial recently published in the New England...
A recent study from the USA has provided a comparison of prescription and over-the-counter medicines, and dietary supplements patterns during two periods, a decade apart. The subjects were comparable, nationally representative samples of community-dwelling older...
